Benefits of Partnering with Apotex
Apotex is ranked 7th in the global generic pharmaceutical market and first in Canada for prescriptions filled, sales volume and value.
We are a vertically integrated company with expertise in API & finished dosage forms that have earned a reputation for providing customers and patients with affordable, high quality medicines.
We aspire to become of Partner of Choice with select third parties where they can offer:
- Early to market opportunities
- non-infringing API and/or formulations
- Currently approved and/or filed products
- Contract development and/or manufacturing
- New Technologies
Dosage Forms Apotex does not currently manufacture:
- Dry Powder Inhalers
- Metered Dose Inhalers
- Nano particles
- Depots/ Long Acting injectables
- Semi-Synthetic Penicillins
- Pre-filled Syringes
Schedule II controlled drugs (USA only)
- Ointments and gels
- Soft and Hard gelatin capsules
Apotex has substantial experience and expertise in identifying, developing, registering and litigating early-to-market products including Paragraph IV opportunities.
In addition to in-licensing, Apotex co-develops certain dosage forms and products where there is an opportunity for Apotex to contribute to the formulation, analytical development or clinical development.